Bioengineered human skin from embryonic stem cells

The Lancet

Volumn 374, Issue 9703, 2009, Pages 1725-1726

  Schlüter, Holger ^a   Kaur, Pritinder ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL SKIN; BURN; CANCER RISK; DERMIS; EMBRYONIC STEM CELL; GOOD MANUFACTURING PRACTICE; HUMAN; PRIORITY JOURNAL; SKIN GRAFT; TISSUE ENGINEERING;

EID: 70449636045     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61707-4     Document Type: Note

References (14)

1. Gallico III G.G., O'Connor N.E., Compton C.C., Kehinde O., and Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311 (1984) 448-451
2. Ronfard V., Rives J.M., Neveux Y., Carsin H., and Barrandon Y. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 70 (2000) 1588-1598
3. Bagutti C., Hutter C., Chiquet-Ehrismann R., Fassler R., and Watt F.M. Dermal fibroblast-derived growth factors restore the ability of β1 integrin-deficient embryonal stem cells to differentiate into keratinocytes. Dev Biol 231 (2001) 321-333
4. Green H., Easley K., and Iuchi S. Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci USA 100 (2003) 15625-15630
5. Metallo C.M., Ji L., de Pablo J.J., and Palecek S.P. Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells 26 (2008) 372-380
6. Coraux C., Hilmi C., Rouleau M., et al. Reconstituted skin from murine embryonic stem cells. Curr Biol 13 (2003) 849-853
7. Guenou H., Nissan X., Larcher F., et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 374 (2009) 1745-1753
8. Drukker M., Katz G., Urbach A., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99 (2002) 9864-9869
9. Li L., Baroja M.L., Majumdar A., et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22 (2004) 448-456
10. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18 (2000) 399-404
11. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
12. Brederlau A., Correia A.S., Anisimov S.V., et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24 (2006) 1433-1440
13. Carpenter M.K., Frey-Vasconcells J., and Rao M.S. Developing safe therapies from human pluripotent stem cells. Nat Biotechnol 27 (2009) 606-613
14. Mavilio F., Pellegrini G., Ferrari S., et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12 (2006) 1397-1402